Factors associated with weight gain and hypoglycaemia and the impact upon hospitalisation in type 2 diabetes patients managed with metformin plus sulfonylurea

被引：0
|
作者：
Gordon, J. [1 ]
McEwan, P. [1 ,2 ]
Evans, M. [3 ]
Puelles, J. [4 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Monmouth, England
[2] Swansea Univ, Ctr Hlth Econ, London, England
[3] Cardif & Vale Univ Hlth Board, London, England
[4] Takeda Global Res & Dev, London, England
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
327
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [1] FACTORS ASSOCIATED WITH WEIGHT GAIN AND HYPOGLYCAEMIA AND THE IMPACT UPON HOSPITALISATION IN TYPE 2 DIABETES PATIENTS MANAGED WITH METFORMIN PLUS SULPHONYLUREA
    McEwan, P.
    Gordon, J.
    Evans, M.
    Puelles, J.
    VALUE IN HEALTH, 2014, 17 (07) : A360 - A360
  • [2] Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
    Gordon, Jason P.
    Evans, Marc
    Puelles, Jorge
    McEwan, Philip C.
    DIABETES THERAPY, 2015, 6 (04) : 495 - 507
  • [3] Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
    Jason P. Gordon
    Marc Evans
    Jorge Puelles
    Philip C. McEwan
    Diabetes Therapy, 2015, 6 : 495 - 507
  • [4] Achievement of weight loss with canagliflozin, sitagliptin and glimepiride in combination with metformin or metformin plus sulfonylurea in patients with Type 2 diabetes
    Stein, L.
    Thompson, G.
    Diels, J.
    Thilakarathne, P.
    Girod, I.
    DIABETIC MEDICINE, 2014, 31 : 145 - 145
  • [5] Empagliflozin as add-on to metformin plus sulfonylurea in patients with Type 2 diabetes
    Haering, H. U.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [6] One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
    Hanefeld, M
    Brunetti, P
    Schernthaner, GH
    Matthews, DR
    Charbonnel, BH
    DIABETES CARE, 2004, 27 (01) : 141 - 147
  • [7] Linagliptin Improves Glycemic Control in Type 2 Diabetes Patients Inadequately Controlled by Metformin and Sulfonylurea without Weight Gain or Hypoglycemia
    Owens, David R.
    Swallow, Ros
    Jones, Peter
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    DIABETES, 2010, 59 : A149 - A149
  • [8] Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes
    Derosa, G.
    Maffioli, P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (03) : 265 - 270
  • [9] Risk of Cardiovascular Disease Associated with Sulfonylurea or Metformin Use in Older Patients with Type 2 Diabetes
    Fu, Alex Z.
    Qiu, Ying
    Davies, Michael J.
    Engel, Samuel S.
    DIABETES, 2011, 60 : A10 - A10
  • [10] DISORDERS OF PULMONARY FUNCTION IN TYPE 2 DIABETES MELLITUS PATIENTS WITH DIFFERENT TYPES OF ORAL HYPOGLYCEMIC MEDICATIONS: METFORMIN, METFORMIN PLUS THIAZOLIDINEDIONE AND METFORMIN PLUS SULFONYLUREA
    Abdulsaied, Rua'a Tariq
    Jabbar, Azza Sajid
    Akar, Talib Kadhim
    FARMACIA, 2022, 70 (06) : 1050 - 1056
12345